Aberrant level and somatic activating mutations in KRAS gene are pervasively found in human cancers, inclusive of CRC,5 pancreatic cancer,6 gastric cancer,7 breast cancer,8 and lung cancer.9 In this regard, targeting KRAS gene is promising to treat cancers like CRC. This evidence concerns the gene KRAS and lung cancer.